FDA Approves GLP-1 for Cardiovascular Risk Reduction
Share on PinterestThe FDA has approved Mounjaro for cardiovascular risk reduction in people with type 2 diabetes. Milko ยท E+/Getty The FDA has approved Mounjaro to help reduce the risk of major cardiovascular events in people with type 2 diabetes who are at high risk. A major clinical trial found that Mounjaro performed as well […]
